-
BTIG Research Reaffirms Buy Rating for Humacyte (NASDAQ:HUMA)
来源: Buzz FX / 18 10月 2024 10:46:13 America/Chicago
Written by MarketBeatOctober 18, 2024 ShareLink copied to clipboard. Humacyte (NASDAQ:HUMA - Get Free Report)'s stock had its "buy" rating restated by equities research analysts at BTIG Research in a research report issued on Friday, Benzin
Read more...